NovaBay Pharmaceuticals Inc (NBY)
0.0773
0.00 (0.00%)
USD |
NYAM |
Apr 24, 16:00
0.0751
0.00 (0.00%)
After-Hours: 05:53
NovaBay Pharmaceuticals Revenue (Quarterly): 3.727M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.727M |
| September 30, 2023 | 3.265M |
| June 30, 2023 | 4.61M |
| March 31, 2023 | 3.124M |
| December 31, 2022 | 3.643M |
| September 30, 2022 | 3.826M |
| June 30, 2022 | 3.662M |
| March 31, 2022 | 3.273M |
| December 31, 2021 | 3.173M |
| September 30, 2021 | 2.265M |
| June 30, 2021 | 2.133M |
| March 31, 2021 | 1.807M |
| December 31, 2020 | 1.888M |
| September 30, 2020 | 2.17M |
| June 30, 2020 | 3.984M |
| March 31, 2020 | 1.892M |
| December 31, 2019 | 1.704M |
| September 30, 2019 | 1.615M |
| June 30, 2019 | 1.789M |
| March 31, 2019 | 1.491M |
| December 31, 2018 | 3.625M |
| September 30, 2018 | 3.142M |
| June 30, 2018 | 2.794M |
| March 31, 2018 | 2.947M |
| December 31, 2017 | 6.316M |
| Date | Value |
|---|---|
| September 30, 2017 | 4.091M |
| June 30, 2017 | 4.122M |
| March 31, 2017 | 3.701M |
| December 31, 2016 | 4.077M |
| September 30, 2016 | 3.438M |
| June 30, 2016 | 2.663M |
| March 31, 2016 | 1.719M |
| December 31, 2015 | 1.635M |
| September 30, 2015 | 1.20M |
| June 30, 2015 | 1.008M |
| March 31, 2015 | 0.538M |
| December 31, 2014 | 0.491M |
| September 30, 2014 | 0.152M |
| June 30, 2014 | 0.123M |
| March 31, 2014 | 0.288M |
| December 31, 2013 | 0.51M |
| September 30, 2013 | 1.099M |
| June 30, 2013 | 0.848M |
| March 31, 2013 | 1.02M |
| December 31, 2012 | 1.113M |
| September 30, 2012 | 3.642M |
| June 30, 2012 | 0.871M |
| March 31, 2012 | 1.32M |
| December 31, 2011 | 1.23M |
| September 30, 2011 | 2.772M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.615M
Minimum
Sep 2019
4.61M
Maximum
Jun 2023
2.818M
Average
3.124M
Median
Mar 2023
Revenue (Quarterly) Benchmarks
| Eyenovia Inc | 0.0026M |
| Palatin Technologies Inc | 2.034M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.108M |
| Total Expenses (Quarterly) | 4.525M |
| EPS Diluted (Quarterly) | -0.8165 |
| Enterprise Value | 2.284M |
| Gross Profit Margin (Quarterly) | 48.70% |
| Profit Margin (Quarterly) | -110.2% |
| Earnings Yield | -4.28K% |
| Normalized Earnings Yield | -4088.66 |